Clinical trial

A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy

NCT00785928

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-10-01

PhasePHASE2

Study timeline

Study start (unknown)2008-10-01Date precision: month

Registry last updated2018-07-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

LY2127399BIOLOGICAL

PlaceboDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States1 DallasTexas, United States1 WarsawPoland1 BudapestHungary1 Buenos AiresArgentina1 KrakowPoland1 PoznanPoland1 WroclawPoland1 BialystokPoland1 LublinPoland1 LeipzigGermany1 Mexico CityMexico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00785928 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.